102 related articles for article (PubMed ID: 1645616)
1. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
[TBL] [Abstract][Full Text] [Related]
2. Determinants of drug response in a cisplatin-resistant human lung cancer cell line.
Fujiwara Y; Sugimoto Y; Kasahara K; Bungo M; Yamakido M; Tew KD; Saijo N
Jpn J Cancer Res; 1990 May; 81(5):527-35. PubMed ID: 2116401
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.
Kikuchi Y; Hirata J; Yamamoto K; Ishii K; Kita T; Kudoh K; Tode T; Nagata I; Taniguchi K; Kuwano M
Jpn J Cancer Res; 1997 Feb; 88(2):213-7. PubMed ID: 9119751
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells.
Arioka H; Nishio K; Ishida T; Fukumoto H; Fukuoka K; Nomoto T; Kurokawa H; Yokote H; Abe S; Saijo N
Jpn J Cancer Res; 1999 Jan; 90(1):108-15. PubMed ID: 10076573
[TBL] [Abstract][Full Text] [Related]
5. Pd
Carneiro TJ; Batista de Carvalho ALM; Vojtek M; Laginha RC; Marques MPM; Diniz C; Gil AM
J Med Chem; 2024 Apr; 67(8):6839-6853. PubMed ID: 38590144
[TBL] [Abstract][Full Text] [Related]
6. Is Autophagy Always a Barrier to Cisplatin Therapy?
Xu J; Gewirtz DA
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327655
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.
Liu YP; Zheng CC; Huang YN; He ML; Xu WW; Li B
MedComm (2020); 2021 Sep; 2(3):315-340. PubMed ID: 34766149
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET.
Buchtova T; Skrott Z; Chroma K; Rehulka J; Dzubak P; Hajduch M; Lukac D; Arampatzis S; Bartek J; Mistrik M
Mol Oncol; 2022 Apr; 16(7):1541-1554. PubMed ID: 34632694
[TBL] [Abstract][Full Text] [Related]
9. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy.
Tchounwou PB; Dasari S; Noubissi FK; Ray P; Kumar S
J Exp Pharmacol; 2021; 13():303-328. PubMed ID: 33776489
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the treatment response in ovarian cancer: a ctDNA approach.
Sharbatoghli M; Vafaei S; Aboulkheyr Es H; Asadi-Lari M; Totonchi M; Madjd Z
J Ovarian Res; 2020 Oct; 13(1):124. PubMed ID: 33076944
[TBL] [Abstract][Full Text] [Related]
11. The Biological Role of the Collagen Alpha-3 (VI) Chain and Its Cleaved C5 Domain Fragment Endotrophin in Cancer.
Wang J; Pan W
Onco Targets Ther; 2020; 13():5779-5793. PubMed ID: 32606789
[TBL] [Abstract][Full Text] [Related]
12. Oxamusplatin: a cytotoxic Pt(ii) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancer.
Maji M; Karmakar S; Ruturaj ; Gupta A; Mukherjee A
Dalton Trans; 2020 Feb; 49(8):2547-2558. PubMed ID: 32022814
[TBL] [Abstract][Full Text] [Related]
13. New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment.
Chen SH; Chang JY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450627
[TBL] [Abstract][Full Text] [Related]
14. Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors.
Garutti M; Pelizzari G; Bartoletti M; Malfatti MC; Gerratana L; Tell G; Puglisi F
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295913
[TBL] [Abstract][Full Text] [Related]
15. The roles of metallothioneins in carcinogenesis.
Si M; Lang J
J Hematol Oncol; 2018 Aug; 11(1):107. PubMed ID: 30139373
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance in lung cancer.
Shanker M; Willcutts D; Roth JA; Ramesh R
Lung Cancer (Auckl); 2010; 1():23-36. PubMed ID: 28210104
[TBL] [Abstract][Full Text] [Related]
18. Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis.
Na H; Liu X; Li X; Zhang X; Wang Y; Wang Z; Yuan M; Zhang Y; Ren S; Zuo Y
J Hematol Oncol; 2017 Jan; 10(1):28. PubMed ID: 28109307
[TBL] [Abstract][Full Text] [Related]
19. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
[TBL] [Abstract][Full Text] [Related]
20. Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion.
Sakurada T; Yoshikawa M; Sunaga M; Kobayashi E; Satoh N; Yokosuka O; Ueda S
Pharmaceutics; 2010 Sep; 2(3):300-312. PubMed ID: 27721358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
